Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)Luca Durelli, Mauro Zaffaroni, Elisabetta Versino et al.|The Lancet|2002Cited by 552
Recommendations for the diagnosis and treatment of spontaneous intracranial hypotensionElisa Ciceri, Mauro Bergui, Luigi Cirillo et al.|La radiologia medica|2025Cited by 2